▶ 調査レポート

世界の生物保存市場

• 英文タイトル:Biopreservation Market - Growth, Trends, and Forecast (2019 - 2024)

Mordor Intelligenceが調査・発行した産業分析レポートです。世界の生物保存市場 / Biopreservation Market - Growth, Trends, and Forecast (2019 - 2024) / C-MOR-100132資料のイメージです。• レポートコード:C-MOR-100132
• 出版社/出版日:Mordor Intelligence / 2019年9月
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥629,000 (USD4,250)▷ お問い合わせ
  Multi User¥703,000 (USD4,750)▷ お問い合わせ
  Site License¥888,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、生物保存の世界市場について調査・分析し、生物保存の世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。

Market Overview
Global Biopreservation Market is expected witness a CAGR of 15.3% during the forecast period. Certain factors that are driving the market growth include improving healthcare expenditure, adoption of in-house sample storage in hospitals and labs, and increasing R&D investment.

Healthcare expenditure continues to increase faster than economic growth in most countries, maintaining a trend observed over the decades. The presence of equitable, responsive, and efficient health systems across North America, Europe, and Asia-Pacific has also contributed to the maximum possible share of GDP being utilized for healthcare expenditure. Biopreservation has broad public health and socio-economic impacts and is affecting many lives across the world. It has been widely used to preserve cells and tissues, targeting its applications in reproductive medicine and organ transplantation. Stem cell banking and gene banking have also gained global popularity. With growing healthcare expenditure each year, there is growing government collaboration with companies and universities for better exposure to the technology used and its development for higher efficiency, with approval rate of a product in the market. With growing technological advancements in biopreservation and healthcare equipment, along with cost-effectiveness of these instruments, a major share of healthcare spending is going to be invested in this domain.

However, concerns with the transition from laboratory to the market include the major problems of preservation and storage of tissues or cells. Despite the protection, the processes of freezing and thawing often cause tissue damage or cell injury. This factor hinders the growth of the market potential of biopreservation. Tissue cryopreservation is highly complicated and difficult than cryopreservation of individual cells. Injury to cells during freezing and thawing are related to the physicochemical and biophysical changes occurring during cryopreservation.

Scope of the Report

Biopreservation is a process that helps store biological samples for a longer period. Cells, tissues, plasma, and others are some of the common biological samples preserved through biopreservation.

Key Market Trends

Biopreservation Media is Expected to Hold Significant Market Share in the Product Type Segment

Nutrient media has found wide application in stem cell therapy and transplanted organ preservation. Tissue engineering, which includes stem cell storage, has seen prominent usage of nutrient media. Early stage of stem cell culture depends on continuous supply of oxygen and nutrition diffusion. Stem cell engineering has been widely used for treating bone defects. Nutrient media has also been used exclusively for organ preservation and organ transportation. The most common approaches for organ preservation during an organ transplant are simple static cold storage (SCS) and hypothermic machine perfusion (HMP). They are approved for transplantation of liver, lungs, pancreas, heart, and kidney.

North America Dominates the Market and Expected to do Same in the Forecasted Period

The North America market is primarily driven by the rise in demand for preservation of blood, solid tissue specimen, including paraffin-embedded or frozen bio-specimen of tumors, and other tissues, peripheral blood cells and bone marrow, along with stem cells-derived cord blood and its derivatives, across multiple research institutes, pathological centers, and hospitals. Favorable government regulations have also been observed in the country, which are supporting the sharing of biological samples.

Competitive Landscape

The global Biopreservationmarket is highly competitive and consists of a number of major players. Companies like BioCision LLC, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd, Custom Biogenic Systems Inc., Lifeline Scientific Inc., Merck KGaA, Princeton CryoTech Inc., VWR International, among others, hold the substantial market share in the Biopreservation market.

Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Improving Healthcare Expenditure
4.2.2 Adoption of In-House Sample Storage in Hospitals and Labs
4.2.3 Increasing R&D Investment
4.3 Market Restraints
4.3.1 High Cost of the Instruments and its Maintenance
4.3.2 Possibility of Tissue Injury During Preservation and Thawing
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Products
5.1.1 Biopreservation Media
5.1.2 Equipment
5.1.2.1 Temperature Maintaining Units
5.1.2.2 Consumables
5.1.2.3 Others
5.2 Application Area
5.2.1 Biobanking
5.2.2 Regenerative Medicine
5.2.3 Drug Discovery
5.2.4 Others
5.3 End User
5.3.1 Biobanks
5.3.2 Hospitals
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BioCision LLC
6.1.2 BioLife Solutions Inc.
6.1.3 Cesca Therapeutics Inc.
6.1.4 Core Dynamics Ltd
6.1.5 Custom Biogenic Systems Inc.
6.1.6 Lifeline Scientific Inc.
6.1.7 Merck KGaA
6.1.8 Princeton CryoTech Inc.
6.1.9 VWR International
7 MARKET OPPORTUNITIES AND FUTURE TRENDS